GO:0017075 syntaxin-1 binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0017075 (syntaxin-1 binding) is a molecular function defined as binding to a syntaxin-1 SNAP receptor.
• Syntaxin-1 binding proteins regulate SNARE complex assembly and neurotransmitter release [1,2].
• Key syntaxin-1 binding partners include Munc18-1, tomosyn, Mint1, and GAT-1 [3,5,6].
• Syntaxin-1 binding is regulated by conformational changes and post-translational modifications such as S-nitrosylation [7,8].
• Disruption of syntaxin-1 interactions is implicated in neurological and psychiatric disorders [4,6].
• CRISPR-based models (KO, point mutation, knock-in, overexpression) enable functional dissection of syntaxin-1 binding in disease [1,4].
Description
Syntaxin-1 binding (GO:0017075) is a molecular function that describes the physical interaction between a protein and syntaxin-1, a SNAP receptor (SNARE) essential for membrane fusion. Syntaxin-1 is a plasma membrane SNARE that forms part of the core fusion machinery mediating synaptic vesicle exocytosis and neurotransmitter release [1,2]. Proteins that bind syntaxin-1 regulate its conformational state, its availability for SNARE complex formation, and its trafficking, thereby controlling the efficiency and timing of exocytosis [1,4]. This GO term is critical for researchers studying synaptic transmission, neuroendocrine secretion, and the molecular basis of neurological disorders because syntaxin-1 binding events are central to both normal physiology and disease pathogenesis [4,6]. Understanding syntaxin-1 binding at the molecular level provides a framework for identifying therapeutic targets and for designing experiments that test causality of specific interactions in cellular models [1,3].
syntaxin-1 binding At A Glance
| GO ID | GO:0017075 |
|---|---|
| GO term | syntaxin-1 binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to syntaxin-1, a SNAP receptor involved in membrane fusion and exocytosis |
| Related processes | Neurotransmitter release, synaptic vesicle exocytosis, neuroendocrine secretion |
| Key binding partners | Munc18-1, tomosyn, Mint1, GAT-1, and other SNARE regulators |
| Regulation | Conformational changes, phosphorylation, S-nitrosylation, and protein-protein interactions |
What Is GO:0017075?
GO:0017075 (syntaxin-1 binding) is defined by QuickGO as the binding to a syntaxin-1 SNAP receptor. In other words, it is a molecular function term assigned to any protein that physically interacts with syntaxin-1, a member of the SNARE family that mediates membrane fusion. This binding can occur via canonical or non-canonical sites and may regulate syntaxin-1 conformation, localization, or its participation in SNARE complexes [1,3].
Why Is syntaxin-1 binding Important in Cell Biology?
Syntaxin-1 binding is a fundamental molecular function that governs the assembly and regulation of the SNARE complex, the core machinery for synaptic vesicle fusion and neurotransmitter release [1,2]. Dysregulation of syntaxin-1 interactions has been linked to neurological disorders, including stroke and potentially other conditions where synaptic transmission is impaired [4,6]. Because syntaxin-1 binding proteins such as Munc18-1 and tomosyn are essential for setting the fidelity of exocytosis, this GO term is a focal point for understanding both normal brain function and disease mechanisms [3,5].
• Syntaxin-1 binding is required for SNARE complex assembly and membrane fusion.
• It regulates the speed and Ca2+ sensitivity of neurotransmitter release [1,2].
• Munc18-1 binding to syntaxin-1 is essential for synaptic vesicle exocytosis.
• Tomosyn acts as a syntaxin-1-binding protein that negatively regulates release.
• Disruption of GAT-1-syntaxin1A interaction affects recovery after stroke.
• Conformational states of syntaxin-1 determine N-peptide binding requirements.
• S-nitrosylation of syntaxin-1 modulates Munc18-1 binding.
• Syntaxin-1 binding is implicated in neuroendocrine secretion.
• It is a target for understanding exocytosis in health and disease [1,4].
• CRISPR models enable causal testing of syntaxin-1 binding in disease [1,4].
What Happens During syntaxin-1 binding?
Initial recognition and conformational transition
In simple terms: Syntaxin-1 changes shape to allow partner proteins to bind.
Syntaxin-1 exists in a closed conformation that is autoinhibited; binding to proteins such as Munc18-1 stabilizes this closed state or facilitates the transition to an open state competent for SNARE assembly [1,3]. The N-terminal peptide of syntaxin-1 can modulate these conformational states, and its requirement for exocytosis depends on the cellular context.
Formation of regulatory complexes
In simple terms: Binding partners assemble into complexes that control when and where fusion occurs.
Munc18-1 binds syntaxin-1 and is essential for synaptic vesicle exocytosis; a non-canonical target-binding site in Munc18-1 domain 3b mediates assembly of the Mint1-Munc18-1-syntaxin-1 complex. Tomosyn is another syntaxin-1-binding protein that forms a novel complex and acts as a negative regulator of neurotransmitter release.
Modulation by post-translational modifications
In simple terms: Chemical tags on syntaxin-1 can switch binding on or off.
S-nitrosylation of syntaxin-1 at Cys145 acts as a regulatory switch controlling Munc18-1 binding, thereby influencing SNARE complex formation. Such modifications provide a dynamic layer of control over syntaxin-1 interactions in response to cellular signals.
Integration with membrane fusion
In simple terms: Binding events set the stage for vesicle fusion and release.
Syntaxin-1 binding proteins regulate the availability of syntaxin-1 for assembly with VAMP and SNAP-25 to form the SNARE complex, which drives membrane fusion [1,2]. In neuroendocrine cells, functional regulation of syntaxin-1 mediates exocytosis, highlighting its broad role beyond neurons.
Key Genes Involved in GO:0017075 syntaxin-1 binding
The following genes and proteins are central to syntaxin-1 binding and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STX1A | Syntaxin-1A, plasma membrane SNARE | Core component of fusion machinery; target of binding proteins [1,4] |
| STX1B | Syntaxin-1B, neuronal SNARE | Paralog of STX1A; involved in synaptic transmission |
| STXBP1 | Munc18-1, syntaxin-1 binding protein | Essential for exocytosis; mutations cause encephalopathy |
| TOMOSYN (STXBP5) | Syntaxin-1-binding protein | Negative regulator of neurotransmitter release |
| MINT1 (APBA1) | Munc18-1 interactor | Forms Mint1-Munc18-1-syntaxin-1 complex |
| GAT-1 (SLC6A1) | GABA transporter | Interacts with syntaxin1A; stroke recovery |
| VAMP2 | v-SNARE | Partners with syntaxin-1 in SNARE complex |
| SNAP25 | t-SNARE | Forms SNARE complex with syntaxin-1 |
| CSP (DNAJC5) | Co-chaperone | Regulates SNARE complex assembly |
| Complexin | SNARE regulator | Binds syntaxin-1 to clamp fusion |
| Synaptotagmin-1 | Ca2+ sensor | Interacts with syntaxin-1 during fusion |
| NSF | AAA+ ATPase | Disassembles SNARE complexes |
| α-SNAP | SNARE adaptor | Assists NSF in SNARE disassembly |
| Munc13 | Priming factor | Regulates syntaxin-1 open state |
| RIM | Active zone protein | Scaffolds Munc13 and syntaxin-1 |
| Tomosyn-2 | Syntaxin-1 binding protein | Regulates exocytosis in neuroendocrine cells |
| SNAP-29 | SNARE | Modulates syntaxin-1 function |
How Is syntaxin-1 binding Regulated?
Syntaxin-1 binding is regulated by conformational transitions of syntaxin-1 itself, which can be influenced by the N-peptide and by binding partners such as Munc18-1. Post-translational modification, notably S-nitrosylation at Cys145, directly controls Munc18-1 binding and thus SNARE complex assembly. Additionally, proteins like tomosyn can compete with other partners to negatively regulate release. These regulatory layers ensure that syntaxin-1 binding is tightly coupled to cellular signals and the availability of other SNARE components [1,4].
syntaxin-1 binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STXBP1 | Epileptic encephalopathy | Knockout or point-mutation in neurons |
| STX1A | Stroke recovery, synaptic dysfunction | Knock-in of binding-deficient mutant |
| TOMOSYN | Neurotransmitter release dysregulation | Overexpression in neuroendocrine cells |
| GAT-1 (SLC6A1) | Stroke, GABAergic dysfunction | Knockout or point mutation in mice |
| MUNC18-1 | Neurodevelopmental disorders | Conditional knockout in mouse brain |
Neurological and synaptic disorders
Dysregulation of syntaxin-1 binding is linked to impaired neurotransmitter release and neurological conditions. For example, disrupting the stroke-induced GAT-1-syntaxin1A interaction promotes functional recovery after stroke, indicating that this binding event is a therapeutic target. Mutations in STXBP1 (Munc18-1), a key syntaxin-1 binding protein, cause early infantile epileptic encephalopathy, underscoring the clinical importance of this interaction.
Neuroendocrine and metabolic implications
Syntaxin-1 binding also regulates exocytosis in neuroendocrine cells, affecting hormone and peptide secretion. This broader role suggests that syntaxin-1 interactions may contribute to metabolic and endocrine disorders, although specific disease links require further study.
Potential in cancer and other diseases
While direct evidence for syntaxin-1 binding in cancer is limited, SNARE-mediated exocytosis is increasingly recognized in tumor progression. However, the provided citations focus on neurological and neuroendocrine contexts, so cancer associations remain speculative [1,4].
From syntaxin-1 binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does syntaxin-1 binding regulate neurotransmitter release? | Knockout of binding partner in neurons |
| What is the role of S-nitrosylation in Munc18-1 binding? | Point mutation at Cys145 of syntaxin-1 |
| How does GAT-1-syntaxin1A interaction affect stroke recovery? | Knock-in of binding-deficient GAT-1 |
| Can tomosyn overexpression inhibit exocytosis? | Overexpression in neuroendocrine cells |
| What is the impact of Munc18-1 domain 3b mutation? | Point mutation knock-in in mice |
| Does syntaxin-1 N-peptide binding matter in PC12 cells? | Knockout of N-peptide binding site |
How to Study the syntaxin-1 binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Protein-protein interaction | Detect syntaxin-1 binding partners |
| GST pull-down | Direct binding | Map binding domains |
| Cryo-EM | 3D structure | Visualize SNARE complexes |
| Patch-clamp | Neurotransmitter release | Assess exocytosis in neurons |
| Amperometry | Vesicle fusion | Measure secretion in neuroendocrine cells |
| Mass spectrometry | Post-translational modifications | Identify S-nitrosylation sites |
| Live-cell imaging | Protein localization | Track syntaxin-1 trafficking |
| CRISPR knockout | Gene function | Test requirement of binding partners |
Biochemical binding assays
Co-immunoprecipitation, GST pull-down, and isothermal titration calorimetry can measure direct binding between syntaxin-1 and candidate proteins. These methods are foundational for assigning GO:0017075 and for quantifying binding affinities [1,3].
Structural biology
X-ray crystallography and cryo-EM have revealed the atomic details of syntaxin-1 in complex with Munc18-1 and other partners, providing mechanistic insights into conformational states [1,3].
Functional assays in cells
Live-cell imaging, patch-clamp electrophysiology, and amperometry in neuroendocrine cells measure exocytosis and can be combined with CRISPR knockouts or point mutations to test the role of specific binding events [4,7].
Post-translational modification analysis
Mass spectrometry and site-specific antibodies can detect S-nitrosylation or phosphorylation of syntaxin-1, linking modifications to changes in binding.
How CRISPR Can Be Used to Study GO:0017075 syntaxin-1 binding
Knockout
CRISPR knockout of syntaxin-1 binding partners such as STXBP1 or TOMOSYN can reveal their essential roles in exocytosis and neurotransmitter release. For example, knockout of Munc18-1 abolishes synaptic vesicle fusion, demonstrating its non-redundant function.
Point Mutation
Introducing point mutations that disrupt specific binding interfaces, such as the Cys145 site for S-nitrosylation or the Munc18-1 domain 3b, allows precise testing of binding contribution without eliminating the protein [3,8].
Knock-in
Knock-in of disease-associated mutations or binding-deficient variants can model human conditions. For instance, knocking in a GAT-1 mutant that cannot bind syntaxin1A could mimic stroke-related dysfunction.
Overexpression
Overexpression of syntaxin-1 binding proteins like tomosyn can suppress exocytosis, providing a gain-of-function approach to study regulation.
How EDITGENE Supports syntaxin-1 binding Research
Researchers studying syntaxin-1 binding-related genes often need to determine whether a candidate gene is causally involved in exocytosis, synaptic transmission, or disease. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for syntaxin-1 binding research.
Frequently Asked Questions About syntaxin-1 binding
What is syntaxin-1 binding?
Syntaxin-1 binding (GO:0017075) is a molecular function describing the binding to syntaxin-1, a SNAP receptor involved in membrane fusion.
What genes are involved in syntaxin-1 binding?
Key genes include STX1A, STX1B, STXBP1 (Munc18-1), TOMOSYN, and MINT1, among others [1,3,5].
How is syntaxin-1 binding regulated?
It is regulated by conformational changes, S-nitrosylation, and interactions with proteins like Munc18-1 and tomosyn [5,7,8].
What diseases are associated with syntaxin-1 binding?
Disruptions are linked to neurological disorders such as stroke and epileptic encephalopathy [3,6].
What methods study syntaxin-1 binding?
Co-immunoprecipitation, structural biology, electrophysiology, and CRISPR screens are commonly used [1,3,4].
Can CRISPR be used to study syntaxin-1 binding?
Yes, knockout, point mutation, knock-in, and overexpression models enable functional dissection [1,3,6].
What is the role of Munc18-1 in syntaxin-1 binding?
Munc18-1 binds syntaxin-1 and is essential for synaptic vesicle exocytosis.
How does tomosyn affect syntaxin-1?
Tomosyn binds syntaxin-1 and negatively regulates neurotransmitter release.
What is the significance of S-nitrosylation in syntaxin-1 binding?
S-nitrosylation at Cys145 controls Munc18-1 binding and SNARE complex assembly.
Where can I find validated CRISPR models for syntaxin-1 binding?
EDITGENE offers custom CRISPR services for knockout, point mutation, knock-in, and overexpression of syntaxin-1 binding genes [1,4].
Conclusion
Syntaxin-1 binding (GO:0017075) is a central molecular function in SNARE-mediated membrane fusion, with critical roles in neurotransmitter release and neuroendocrine secretion [1,2]. Its dysregulation contributes to neurological disorders, making it a valuable target for therapeutic intervention [3,6]. Advanced CRISPR technologies now allow precise manipulation of syntaxin-1 binding interactions, paving the way for deeper mechanistic insights and potential clinical applications [1,4].
References
- 1. Rizo J. 2022. Molecular Mechanisms Underlying Neurotransmitter Release.. Annu Rev Biophys 51:377-408 PMID: 35167762
- 2. Südhof TC et al.. 1993. Molecular approaches to synaptic vesicle exocytosis.. Prog Brain Res 98:235-40 PMID: 8248512
- 3. Li W et al.. 2023. A non-canonical target-binding site in Munc18-1 domain 3b for assembling the Mint1-Munc18-1-syntaxin-1 complex.. Structure 31(1):68-77.e5 PMID: 36608665
- 4. Yang X et al.. 2023. Functional regulation of syntaxin-1: An underlying mechanism mediating exocytosis in neuroendocrine cells.. Front Endocrinol (Lausanne) 14:1096365 PMID: 36742381
- 5. Fujita Y et al.. 1998. Tomosyn: a syntaxin-1-binding protein that forms a novel complex in the neurotransmitter release process.. Neuron 20(5):905-15 PMID: 9620695
- 6. Lin YH et al.. 2024. Disrupting stroke-induced GAT-1-syntaxin1A interaction promotes functional recovery after stroke.. Cell Rep Med 5(11):101789 PMID: 39423810
- 7. Park S et al.. 2016. Conformational states of syntaxin-1 govern the necessity of N-peptide binding in exocytosis of PC12 cells and Caenorhabditis elegans.. Mol Biol Cell 27(4):669-85 PMID: 26700321
- 8. Palmer ZJ et al.. 2008. S-nitrosylation of syntaxin 1 at Cys(145) is a regulatory switch controlling Munc18-1 binding.. Biochem J 413(3):479-91 PMID: 18452404
